THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Jefferies Financial Group Inc.'s Holding History (CIK: 0000096223)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 276,887 Value ($000) $3,054 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 21,432 Value ($000) $191 Avg Close $9.31 Range $8.35 - $10.90

Q3 2023

Shares 302,130 Value ($000) $2,607 Avg Close $9.65 Range $8.25 - $10.59

Q2 2023

Shares 300,000 Value ($000) $3,105 Avg Close $11.04 Range $9.98 - $12.03

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	276,887	$3,054	$9.72	$7.90 - $11.82
Q1 2025	21,432	$191	$9.31	$8.35 - $10.90
Q3 2023	302,130	$2,607	$9.65	$8.25 - $10.59
Q2 2023	300,000	$3,105	$11.04	$9.98 - $12.03